A systematic review of the bimanual examination as a test for ovarian cancer

American Journal of Preventive Medicine

Volumn 48, Issue 3, 2015, Pages 350-356

  Ebell, Mark H ^a   Culp, Marybeth ^a   Lastinger, Krista ^a   Dasigi, Tara ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; MEDLINE; META ANALYSIS; OVARY CANCER; PELVIC EXAMINATION; PREDICTIVE VALUE; QUALITY CONTROL; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STUDY DESIGN; SYSTEMATIC REVIEW; EARLY DIAGNOSIS; FEMALE; GYNECOLOGICAL EXAMINATION; OVARIAN NEOPLASMS; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; STATISTICS AND NUMERICAL DATA; WOMEN'S HEALTH;

EARLY DETECTION OF CANCER; FEMALE; GYNECOLOGICAL EXAMINATION; HUMANS; OVARIAN NEOPLASMS; ROC CURVE; SENSITIVITY AND SPECIFICITY; WOMEN'S HEALTH;

EID: 84926181803     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2014.10.007     Document Type: Article

References (35)

1. Committee on Gynecologic Practice Committee opinion no. 534: well-woman visit Obstet Gynecol 120 2 Pt 1 2012 421 424
2. J. Schachter, M. Schafer, M. Young, and M. Ott Routine pelvic examinations in asymptomatic young women N Engl J Med 334 1996 1847 1848
3. A.R. Stormo, N.A. Hawkins, C.P. Cooper, and M. Saraiya The pelvic examination as a screening tool: practices of US physicians Arch Intern Med 171 22 2011 2053 2054
4. J.T. Henderson, C.C. Harper, and S. Gutin Routine bimanual pelvic examinations: practices and beliefs of US obstetrician-gynecologists Am J Obstet Gynecol 208 2 2013 109.e1-7
5. American Cancer Society guidelines for the early detection of cancer, 2013. www.cancer.org/healthy/findcancerearly/cancerscreeningguidelines/american-cancer-society-guidelines-for-the-early-detection-of-cancer.
6. U.S. Preventive Services Task Force Screening for ovarian cancer: recommendation statement Ann Fam Med 2 3 2004 260 262 dx.doi.org/10.1370/afm.200
7. V.A. Moyer U.S. Preventive Services Task Force. Screening for ovarian cancer: USPSTF reaffirmation recommendation statement Ann Intern Med 157 12 2012 900 904
8. F.H. Stewart, C.C. Harper, and C.E. Ellertson Clinical breast and pelvic examination requirements for hormonal contraception: current practice vs evidence JAMA 285 17 2001 2232 2239
9. J.T. Henderson, G.F. Sawaya, and M. Blum Pelvic examinations and access to oral hormonal contraception Obstet Gynecol 116 6 2010 1257 1264
10. D.M. Reddy, and S.A. Wasserman Patient anxiety during gynecologic examinations. Behavioral indicators J Reprod Med 42 10 1997 631 636
11. N.L. Lacy, A. Paulman, and B. Lovejoy Why we don't come: patient perceptions on no-shows Ann Fam Med 2 6 2004 541 545
12. G.T. Nguyen, and P.F. Cronholm The annual pelvic examination: preventive time not well spent Am Fam Physician 87 1 2013 8 9
13. E.R. Myers, L.A. Bastian, and L.J. Havrilesky Management of adnexal mass. Evidence report/technology assessment No. 130 (prepared by the Duke Evidence-based Practice Center under Contract No. 290-02-0025.) AHRQ Publication No. 06-E004 February 2006 Agency for Healthcare Research and Quality Rockville MD
14. J.G. Lijmer, B.W. Mol, and S. Heisterkamp Empirical evidence of design-related bias in studies of diagnostic tests JAMA 282 11 1999 1061 1066
15. 2) estimates and their 95% confidence intervals in large meta-analyses PLoS One 7 7 2012 e39471
16. B.A. Dwamena MIDAS: a program for meta-analytical integration of diagnostic accuracy studies in Stata 2007 Division of Nuclear Medicine, Department of Radiology, University of Michigan Medical School Ann Arbor, MI
17. I. Jacobs, J. Bridges, and C. Reynolds Multimodal approach to screening for ovarian cancer Lancet 331 8580 1988 268 271
18. J.R. van Nagell Jr, P.D. DePriest, and F.R. Ueland Ovarian cancer screening with annual transvaginal sonography Cancer 109 9 2007 1887 1896
19. S.R. Grover, and M.A. Quinn Is there any value in bimanual pelvic examination as a screening test? Med J Aust 162 8 1995 408 410
20. G.L. Adonakis, E. Paraskevaidis, and S. Tsiga A combined approach for the early detection of ovarian cancer in asymptomatic women Eur J Obstet Gynecol Reprod Biol 65 2 1996 221 225
21. A. Kurjak, M. Prka, and J.M. Arenas Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women Croat Med J 46 5 2005 757 764
22. A.L. Oei, L.F. Massuger, and J. Bulten Surveillance of women at high risk for hereditary ovarian cancer is inefficient Br J Cancer 94 6 2006 814 819
23. R.I. Olivier, M.A. Lubsen-Brandsma, S. Verhoef, and M. van Buerden CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer Gynecol Oncol 100 1 2006 20 26
24. N.M. van der Velde, M.J. Mourits, and H.J. Arts Time to stop ovarian cancer screening in BRCA1/2 mutation carriers? Int J Cancer 124 4 2009 919 923
25. G.C. Balbi, R. Musone, and A. Menditto Women with a pelvic mass: indicators of malignancy Eur J Gynaecol Oncol 22 6 2001 459 462
26. K. Buckshee, I. Temsu, N. Bhatla, and D. Deka Pelvic examination, transvaginal ultrasound and transvaginal color Doppler sonography as predictors of ovarian cancer Int J Gynaecol Obstet 61 1 1998 51 57
27. M.R. Buist, R.P. Golding, and C.W. Burger Comparative evaluation of diagnostic methods in ovarian carcinoma with emphasis on CT and MRI Gynecol Oncol 52 2 1994 191 198
28. N.J. Finkler, B. Benacerraf, and P.T. Lavin Comparison of serum CA 125, clinical impression, and ultrasound in the preoperative evaluation of ovarian masses Obstet Gynecol 72 4 1988 659 664
29. F. Ghaemmaghami, F. Fakour, and M.K. Zarchi Clinical assessment, gross examination, frozen section of ovarian masses: do patients benefit? Arch Gynaecol Obstet 278 3 2008 209 213
30. L.D. Roman, L.I. Muderspach, and S.M. Stein Pelvic examination, tumor marker level, and gray-scale and Doppler sonography in the prediction of pelvic cancer Obstet Gynecol 89 4 1997 493 500
31. E.M. Schutter, P. Kenemans, and C. Sohn Diagnostic value of pelvic examination, ultrasound, and serum CA125 in postmenopausal women with a pelvic mass Cancer 74 4 1994 1398 1406
32. S.S. Buys, E. Partridge, A. Black for the PLCO Project Team Effect of screening on ovarian cancer mortality. The Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening randomized controlled trial JAMA 305 22 2011 2295 2303
33. I. Jacobs, D. Oram, and J. Fairbanks A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer Br J Obstet Gynaecol 97 10 1990 922 929
34. Y. Yamamoto, R. Yamada, and H. Oguri Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses Eur J Obstet Gynecol Reprod Biol 144 2 2009 163 167
35. R.A. Stewart Routine pelvic examination for asymptomatic women: exploring the evidence Aust Fam Physician 35 11 2006 873 876